PMDA drug package insert
リフェンダ点鼻薬BE〈季節性アレルギー専用〉
PMDA OTC drug · （株）タカミツ · package insert May 21, 2022
Key facts
| Brand names | リフェンダ点鼻薬BE〈季節性アレルギー専用〉 |
|---|---|
| Companies | 製造販売元／（株）タカミツ |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 噴霧剤 |
| OTC effect category | 鼻炎用点鼻薬 |
| Package insert date | May 21, 2022 |
| PMDA document key | 400206_J2201000054 |
| PMDA company code | 400206 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: